FDA Inspection 1165719 — Element Materials Technology Oakland-Concord

Element Materials Technology Oakland-Concord — FEI 3006616583

The FDA completed an inspection of Element Materials Technology Oakland-Concord on March 22, 2022 in Concord, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 14 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Concord, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
119421 CFR 211.42(c)Defined areas of adequate size for operations
122321 CFR 211.67(b)(5)Cleaning SOPs/equipment protection
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
143321 CFR 211.42(c)(10)(iii)Air Supply
143521 CFR 211.42(c)(10)(v)Cleaning System
145221 CFR 211.113(b)Validation lacking for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures
354621 CFR 211.46(a)Adequate ventilation not provided
354721 CFR 211.46(b)Equipment for Environmental Control
355521 CFR 211.48(b)Drains--Size, Back-siphonage Prevention
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls